Merck & Co. The Keytruda Market, which is focused on successful immunotherapeutic drugs developed by the Keytruda market is an important part of the global pharmaceutical industry in oncology. keytruda (pembrolizumab) is an inhibitor of the PD-1 immune control point used to treat certain numbers of cancers, including non-cancer (CBNPCs) of the lungs, head and neck, and so on. The main... https://www.metatechinsights.com/industry-insights/keytruda-market-2345